[From NIH website]

Publication of the Revised NIH Grants Policy Statement (Rev. 3/31/2015)


Notice Number: NOT-OD-15-087

On Thursday, April 2nd, our fellows competed against each other in Echo Jeopardy. This event was hosted by world class cardiologist Dr. John Gorcsan from the University of Pittsburgh Medical Center. Dr. Gorcsan has gained an international reputation for this fun and educational event.
The Christ Hospital Health Network (TCHHN) in Cincinnati, Oh., announced today an affiliation with the University of Kentucky Markey Cancer Center, the state's first and only National Cancer Institute-designated cancer center. The affiliation will provide patients with more cancer treatment options and advanced education and research. “We look forward to expanding healthcare choices for patients with cancer with this affiliation,” said Mike Keating, president and CEO of The Christ Hospital Health Network.

Prabha Nagareddy, PhD, was recently notified as a finalist for the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology Irvine H. Page Young Investigator Research Award. The award is given to new investigators in arteriosclerosis and vascular biology. The award recognizes investigators in the formative years of their careers who have the potential to become future leaders in cardiovascular research. Dr.

Binggang Xiang, PhD, core faculty of the Saha Cardiovascular Research Center was recently notified as a finalist for the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology Kenneth M. Brinkhous Young Investigator Prize in Thrombosis. The award recognizes outstanding endeavors by new investigators in fundamental and applied research in thrombosis including the mechanism, detection, treatment, and prevention of thrombotic disorders. Dr.

What if a failed leukemia drug could reduce the risk of Alzheimer’s disease? A team at the University of Kentucky recently led an effort to investigate this hypothesis. Their results were published today in the journal, Human Molecular Genetics. The UK researchers, led by Steve Estus at the Sanders-Brown Center on Aging, study a genetic variant in a gene called CD33 that reduces the risk of Alzheimer’s disease. The Estus group recently published findings suggesting that this variant promotes production of a truncated form of the CD33 protein that lacks a putative functional domain.

Paul Mueller recently received the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology Travel Award for Young Investigators. The $1000 award will be used to attend the ATVB|PVD 2015 Scientific Sessions in San Francisco in May. The award is distributed to a select number of young investigators based on the score of a submitted abstract.

A postdoctoral position is available immediately at the University of Kentucky to study the molecular mechanisms of metabolic disorders and atherosclerosis.  Our laboratory mainly focuses on the role of NF-kB (J Exp Med, 2014; Arterioscler Thromb Vasc Biol, 2012) and nuclear receptor PXR (Environ Health Perspect, 2012; Mol Pharmacol, 2013; JAHA 2014; Mol Endocrinol, 2015) in the pathogenesis of obesity and cardiovascular disease.  More details can be found at the following webpage: http://pharmns.med.uky.edu/use

Shirley Prater distinctly remembers one of the many clients she's served in her six years as a Community Health Worker (CHW) for Kentucky Homeplace. The client was diabetic, but had run out of medication due to financial challenges. 

Part of the submission requirements for NIH Shared Instrumentation and High End Instrumentation Grant Programs is an institutional letter of support.   This letter includes detailed supporting documentation and mulitple level approvals.  Therefore, the VPR office along with PDO are requesting notification now from researchers who may be considering the submission of this type of grant.  The proposals are due to NIH on May 29, 2015.  

Questions - Annette Evans at 257-1663.